Brief: Karyopharm Therapeutics Files Prospectus For Resale
03/11/2025 23:12
Nov 3 (Reuters) - Karyopharm Therapeutics Inc KPTI.O: KARYOPHARM THERAPEUTICS FILES PROSPECTUS FOR RESALE FROM TIME TO TIME OF UP TO 9.57 MILLION COMMON STOCK BY SELLING STOCKHOLDERS-SEC FILING Source text: [ID:n0001193125-25-262571] Further company coverage: KPTI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karyopharm Therapeutics
See all newsBrief: Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
Karyopharm Therapeutics Inc. expected to post a loss of $1.28 a share - Earnings Preview